PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.74%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
0.15%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
-20.25%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
2.69%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
-16.12%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-17.24%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-14.29%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.33%
Share reduction while ADI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.36%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.95%
Dividend reduction while ADI stands at 0.06%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-59.92%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-77.51%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-9.32%
Negative 10Y revenue/share CAGR while ADI stands at 249.37%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
3.28%
5Y revenue/share CAGR under 50% of ADI's 10.14%. Michael Burry would suspect a significant competitive gap or product weakness.
81.70%
3Y revenue/share CAGR above 1.5x ADI's 42.85%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
96.01%
10Y OCF/share CAGR under 50% of ADI's 192.60%. Michael Burry would worry about a persistent underperformance in cash creation.
24.83%
Positive OCF/share growth while ADI is negative. John Neff might see a comparative advantage in operational cash viability.
97.36%
3Y OCF/share CAGR above 1.5x ADI's 1.55%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
56.05%
Below 50% of ADI's 469.89%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-6.33%
Negative 5Y net income/share CAGR while ADI is 7.47%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
1308.11%
3Y net income/share CAGR above 1.5x ADI's 320.78%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
217.61%
Below 50% of ADI's 754.75%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
1.99%
Below 50% of ADI's 98.92%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
12.23%
Below 50% of ADI's 25.25%. Michael Burry suspects a serious short-term disadvantage in building book value.
63.26%
Dividend/share CAGR of 63.26% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
17.88%
Dividend/share CAGR of 17.88% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
29.81%
3Y dividend/share CAGR of 29.81% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
-0.88%
Inventory is declining while ADI stands at 2.14%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-7.69%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-7.64%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-1.58%
We’re deleveraging while ADI stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
1.43%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-4.97%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.